(Q33341415)

25 July 2017

1 reference

title

Oral tegafur/uracil (English)

1 reference

25 July 2017

Wellington K

1

1 reference

25 July 2017

Goa KL

series ordinal

2

1 reference

25 July 2017

publication date

1 January 2001

1 reference

25 July 2017

1 reference

25 July 2017

volume

18

1 reference

25 July 2017

issue

12

1 reference

25 July 2017

page(s)

935-48; discussion 949-50

1 reference

Phase I study of preoperative oral uracil and tegafur plus leucovorin and radiation therapy in rectal cancer

25 July 2017

cites work

1 reference

12 December 2020

Effects of neo-adjuvant chemotherapy with UFT (a combination of tegafur and uracil) on DNA-synthesizing enzyme activities in human colorectal carcinomas

1 reference

12 December 2020

Clinical pharmacology of 5-fluorouracil

1 reference

12 December 2020

Clinical implications of dihydropyrimidine dehydrogenase inhibition.

1 reference

12 December 2020

Phase II trial of uracil and tegafur plus oral leucovorin: an effective oral regimen in the treatment of metastatic colorectal carcinoma

1 reference

12 December 2020

Tegafur-uracil (UFT) plus folinic acid in advanced rectal cancer

1 reference

12 December 2020

5-fluorouracil: a pharmacological paradigm in the use of cytotoxics

1 reference

12 December 2020

UFT plus leucovorin vs 5-FU plus leucovorin for metastatic colorectal cancer.

1 reference

12 December 2020

UFT Plus Oral Leucovorin: A New Oral Treatment for Colorectal Cancer

1 reference

12 December 2020

UFT plus or minus calcium folinate for metastatic colorectal cancer in older patients

1 reference

12 December 2020

Oral uracil and Ftorafur plus leucovorin: pharmacokinetics and toxicity in patients with metastatic cancer

1 reference

12 December 2020

[Concentration of 5-FU level in the tissue and blood of the patients with breast cancer by preoperative administration of UFT]

1 reference

12 December 2020

Uracil and tegafur modulated with leucovorin: an effective regimen with low toxicity for the treatment of colorectal carcinoma in the elderly. Oncopaz Cooperative Group.

1 reference

12 December 2020

The oral fluorouracil prodrugs

1 reference

12 December 2020

Multicenter randomized prospective study of adjuvant chemotherapy with UFT and mitomycin C in advanced colorectal cancer

1 reference

12 December 2020

Phase II study of oral tegafur-uracil and folinic acid as first-line therapy for metastatic colorectal cancer: Taiwan experience

1 reference

12 December 2020

ABC of colorectal cancer: Epidemiology

1 reference

12 December 2020

[Level of inhibition of thymidylate synthase activity and 5-fluorouracil in tumor tissues after administration of UFT or tegafur]

1 reference

12 December 2020

Phase II trial of UFT in advanced colorectal and gastric cancer

1 reference

12 December 2020

Phase I trial of uracil-tegafur (UFT) plus oral leucovorin: 14-day schedule

1 reference

12 December 2020

Effect of coadministration of uracil or cytosine on the anti-tumor activity of clinical doses of 1-(2-tetrahydrofuryl)-5-fluorouracil and level of 5-fluorouracil in rodents

1 reference

12 December 2020

Thymidylate synthase inhibition and concentration of 5-fluorouracil after administration of UFT in human uroepithelial carcinomas

1 reference

12 December 2020

Feasibility of a novel weekday-on/weekend-off oral UFT schedule as postoperative adjuvant chemotherapy for colorectal cancer. UFT Compliance Study Group, Kanagawa, Japan

1 reference

12 December 2020

Phase I study of UFT plus leucovorin in advanced colorectal cancer: a double modulation proposal

1 reference

12 December 2020

5-FU or UFT combined with leucovorin for previously untreated metastatic colorectal Ca

1 reference

12 December 2020

Phase I and pharmacokinetic evaluations of UFT plus oral leucovorin

1 reference

12 December 2020

[Concentration of 5-fluorouracil in the blood and tissues of gastric and colo-rectal cancer patients after oral administration of UFT]

1 reference

12 December 2020

Efficacy of oral tegafur modulation by uracil and leucovorin in advanced colorectal cancer. A phase II study

1 reference

12 December 2020

A pharmacoeconomic comparison of UFT and 5-FU chemotherapy for colorectal cancer in South America

1 reference

12 December 2020

Comparison of 5-fluorouracil pharmacokinetics in patients receiving continuous 5-fluorouracil infusion and oral uracil plus N1-(2'-tetrahydrofuryl)-5-fluorouracil

1 reference

12 December 2020

Phase I trials of uracil-tegafur (UFT) using 5 and 28 day administration schedules: demonstration of schedule-dependent toxicities

1 reference

12 December 2020

Effect of uracil on metabolism of 5-fluorouracil in vitro

1 reference

12 December 2020

Efficacy of UFT plus oral leucovorin in advanced colorectal cancer: a multicenter study

1 reference

12 December 2020

A fixed-ratio combination of uracil and Ftorafur (UFT) with low dose leucovorin. An active oral regimen for advanced colorectal cancer

1 reference

12 December 2020

Phase I and pharmacokinetic study of oral UFT, a combination of the 5-fluorouracil prodrug tegafur and uracil.

1 reference

12 December 2020

[Low-dose cisplatin added to continuous infusion of 5-fluorouracil or oral administration of UFT for inoperable advanced or recurrent colorectal cancer]

1 reference

12 December 2020

Progress in colorectal cancer chemotherapy: how far have we come, how far to go?

1 reference

12 December 2020

Bioavailability and phase II study of oral UFT plus leucovorin in patients with relapsed or refractory colorectal cancer

1 reference

12 December 2020

Tegafur/uracil + calcium folinate in colorectal cancer: double modulation of fluorouracil

1 reference

12 December 2020

[The concentration of 5-fluorouracil in blood and tissues of the patients with carcinoma of the cervix after administration of UFT and 5-fluorouracil]

1 reference

12 December 2020

[Optimal dosage of UFT + MMC combination chemotherapy for advanced colorectal cancer--phase I/II study of combination chemotherapy of MMC with 2-week intervals and intermittent UFT administration--Study Group of UFTM Therapy for Advanced Colorectal

1 reference

12 December 2020

UFT and leucovorin: a review of its clinical development and therapeutic potential in the oral treatment of cancer

1 reference

12 December 2020

Scientific basis for the combination of tegafur with uracil

1 reference

12 December 2020

Oral fluoropyrimidines in the treatment of colorectal cancer

1 reference

12 December 2020

Phase I trial of uracil-tegafur (UFT) plus oral leucovorin: 28-day schedule

1 reference

12 December 2020

A phase I and pharmacokinetic study of oral uracil, ftorafur, and leucovorin in patients with advanced cancer

1 reference

12 December 2020

10.2165/00002512-200118120-00005

Identifiers

DOI

1 reference

Dimensions Publication ID

25 July 2017

1022321175

0 references

1 reference